Consultant haematologist and clinical senior lecturer
Richard Dillon is a consultant haematologist at Guy's and St Thomas' NHS Foundation Trust.
He is also an academic haemato-oncologist (an academic specialising in blood cancer).
His clinical practice focuses on the treatment of acute leukaemias and his academic focus is the molecular biology of acute myeloid leukaemia (AML).
He is involved in clinical trials for AML and leads on molecular diagnostics in the NCRI AML19 and CRUK MyeChild studies.
He is the chief investigator of the VICTOR and BlinAML trials which aim to use advanced diagnostics to provide molecularly guided therapy for patients with AML.
- Molecular biology of AML
- Molecular diagnostics
- Minimal residual disease
- Interventions for molecular failure in AML
Last updated: April 2022